Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Varian, a Siemens Healthineers Company
PMV Pharmaceuticals, Inc
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
UMC Utrecht
University of Chicago
Aktis Oncology, Inc.
Tubulis GmbH
University of California, Irvine
Eli Lilly and Company
ViroMissile, Inc.
Hospices Civils de Lyon
University Health Network, Toronto
Duke University
Washington University School of Medicine